Mumbai

The Institute of Chemical Technology (ICT) Mumbai was established as the Department of Chemical Technology on 1st October, 1933 by the University of Mumbai, through active support of industries and philanthropists. The Institute was most popularly known as UDCT, Mumbai. Research has been an integral part of ICT since its inception and it has created over 500 first generation entrepreneurs. The UDCT grew significantly in stature and was granted autonomy under UGC regulations by the University of Mumbai and further converted in to an Institute on 26th January, 2002.

Post : Junior Research Fellow

National Institute of Immunohaematology was started by ICMR basically to solve problems in blood banking, slowly branched out successfully to initiate research in various other related areas of immunohaematology viz. biochemical genetics , red cell enzymopathies and hemoglobinopathies , population genetics, antenatal serology, Immunology, HLA etc. In the first twenty five years, using limited space, limited resources and budget, talented and highly enthusiastic young scientists from the center under the guidance of dynamic stalwarts Dr. H M Bhatia and Dr. A J Baxi could produce as many as 271 publications of which 71 were published in prestigious international journals. The centre had many discoveries to it's credit. Seeing this progress, ICMR decided to rechristen BGRC as 'Institute of Immunohaematolgy' at the time of the Silver Jubilee Celebrations of the Institute in 1982 to accommodate all the departments of the centre under one roof.

The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) is the new state-of-the-art R&D satellite of the Tata Memorial Centre (TMC), which also includes under its umbrella the Tata Memorial Hospital (TMH), the largest cancer hospital in Asia. ACTREC has the mandate to function as a national centre for treatment, research and education in cancer. TMC is an autonomous grant-in-aid institution of the Department of Atomic Energy (DAE), Government of India. It is registered under the Societies Registration Act (1860) and the Bombay Public Trust Act (1950). Its Governing Council is headed by the Chairman, Atomic Energy Commission, Government of India.

Post : Senior Research Fellow

At BDH, we CARE for QUALITY. Our REPUTATION is the result of that. Our sight is constantly focussed on our single most important goal-providing quality medicines to the people at an affordable price.  Having started off as a fledgling unit in 1935, BDH has grown into a major facility and earned global acclaim. It is today recognised as one of India's leading manufacturers of therapeutic formulations covering wide range of pharmaceuticals.  It goes without saying that the ultimate test of a drug is in its efficacy when administered to the patient in any part of the world. BDH products have emerged with flying colours when subjected to rigorous tests by regulatory authorities in several countries and are registered with the respective drug administrations.  BDH, in the new Millennium, will attempt to improve its performance in single-minded pursuit of its quest to establish new milestones.

Post : Quality Assurance : Manager / Deputy Manager

SHS invites applications from eligible candidates for filling up the following posts on in State as indicated below.

The NRHM is an effort to strengthen the hands of States to carry out the required reforms. The Mission would also provide additional resources to the States to enable them to meet the diverse health needs of the citizens. While recognizing the leadership role of the states in this regard, it is proposed to provide necessary flexibility to the States to take care of the local needs and socio-cultural variations. In turn, States will decentralize planning and implementation arrangements to ensure that need based and community owned District Health Action Plans become the basis for interventions in the health sector. The States would be urged to take up innovative schemes to deal with local issues. Keeping in view the decentralization envisaged under the NRHM, the States would be required to devolve sufficient administrative / financial powers to the PRIs.

Post: Pharmacist

At BDH, we CARE for QUALITY. Our REPUTATION is the result of that. Our sight is constantly focussed on our single most important goal-providing quality medicines to the people at an affordable price.  Having started off as a fledgling unit in 1935, BDH has grown into a major facility and earned global acclaim. It is today recognised as one of India's leading manufacturers of therapeutic formulations covering wide range of pharmaceuticals.  It goes without saying that the ultimate test of a drug is in its efficacy when administered to the patient in any part of the world. BDH products have emerged with flying colours when subjected to rigorous tests by regulatory authorities in several countries and are registered with the respective drug administrations.  BDH, in the new Millennium, will attempt to improve its performance in single-minded pursuit of its quest to establish new milestones.

Post : Production Manager

National Institute for Research in Reproductive Health (NIRRH), formerly known as Institute for Research in Reproduction is a premier research institute of the Indian Council of Medical Research (ICMR). It is situated in the vicinity of a number of hospitals and research institutes in central Mumbai. Since its inception in 1970, it has been making vigorous efforts to improve the reproductive health of people through research, education and health care services.

Post : Research Associate

Apotex is a proudly Canadian, global pharmaceutical company that produces high-quality, affordable medicines (both generic and innovative pharmaceuticals) for patients around the world. We are the 7th largest generic pharmaceutical company globally with more than 12,000 employees and estimated sales of approximately $3 billion. Our fully integrated operation is comprised of four lines of business: Global Generics; Apobiologix; Global Active Pharmaceutical Ingredients (API); and ApoPharma (Innovative Products). With our worldwide manufacturing sites, Apotex can produce up to 24 billion dosages per year. We produce 300 medicines in 4,000 dosages and formats that are exported to 115 countries. Apotex will spend $2 billion over the next 10 years on research and development.

Post : Associate/Sr. Associate - Global Pharmacovigilance

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Compliance Manager